BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16920312)

  • 1. Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging.
    Park Y; Choi D; Kim SH; Kim SH; Kim MJ; Lee J; Lim JH; Lee WJ; Lim HK
    Eur J Radiol; 2006 Sep; 59(3):424-31. PubMed ID: 16920312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the signal- and contrast-to-noise ratios of hepatocellular carcinomas on gadoxetic acid-enhanced dynamic MR imaging.
    Kim HS; Choi D; Kim SH; Lee MW; Lee WJ; Kim YK; Jang KM; Park MJ; Park CK
    Eur J Radiol; 2013 Jan; 82(1):62-8. PubMed ID: 23079045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
    Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
    J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hepatocellular carcinoma with ferucarbotran (resovist)-enhanced breath-hold MR imaging: feasibility of 10 minute-delayed images.
    Saito K; Shindo H; Ozuki T; Ishikawa A; Kotake F; Shimazaki Y; Abe K
    Magn Reson Med Sci; 2008; 7(3):123-30. PubMed ID: 18827455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic characterization of focal hepatic lesions: role of ferucarbotran-enhanced dynamic MR imaging using T2-weighted multishot spin-echo echo-planar sequence.
    Hori M; Murakami T; Kim T; Iannaccone R; Abe H; Onishi H; Tomoda K; Catalano C; Passariello R; Nakamura H
    J Magn Reson Imaging; 2006 Apr; 23(4):509-19. PubMed ID: 16523480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
    Kim YK; Kim CS; Kwak HS; Lee JM
    J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
    Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
    J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran.
    Kim YK; Kim CS; Han YM
    Br J Radiol; 2009 Jun; 82(978):468-84. PubMed ID: 19124563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.
    Kim SH; Choi D; Lim JH; Lee WJ; Jang HJ; Lim HK; Lee SJ; Cho JM; Kim SK; Kim GC
    Korean J Radiol; 2002; 3(2):87-97. PubMed ID: 12087198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced mr imaging versus combined helical CT during arterial portography and CT hepatic arteriography.
    Choi D; Kim S; Lim J; Lee W; Jang H; Lee S; Lim H
    AJR Am J Roentgenol; 2001 Feb; 176(2):475-82. PubMed ID: 11159099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging.
    Chou CT; Chen RC; Chen WT; Lii JM
    Clin Radiol; 2009 Jan; 64(1):22-9. PubMed ID: 19070694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences.
    Kim SH; Choi D; Lim HK; Kim MJ; Jang KM; Kim SH; Lee WJ; Lee J; Jeon YH; Lim JH
    Eur J Radiol; 2006 Sep; 59(3):413-23. PubMed ID: 16678373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation.
    Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
    Kim SH; Choi D; Kim SH; Lim JH; Lee WJ; Kim MJ; Lim HK; Lee SJ
    AJR Am J Roentgenol; 2005 Apr; 184(4):1069-76. PubMed ID: 15788575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.